Capricor Therapeutics Inc
F:4LN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
K
|
Kemper Corp
F:UI2
|
US |
|
L
|
Lithia Motors Inc
SWB:LMO
|
US |
|
C
|
Coterra Energy Inc
DUS:XCQ
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
OTC:IDCBY
|
CN |
|
Expeditors International of Washington Inc
NYSE:EXPD
|
US |
|
Invisio AB
LSE:0R86
|
SE |
|
S
|
Sturm Ruger & Company Inc
SWB:ST2
|
US |
|
F
|
Frontline Ltd
NYSE:FRO
|
BM |
|
M
|
MTU Aero Engines AG
XBER:MTX
|
DE |
|
Cemex SAB de CV
NYSE:CX
|
MX |
|
N
|
NRG Energy Inc
XMUN:NRA
|
US |
|
F
|
Ford Motor Co
LSE:0P4F
|
US |
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
C
|
Covivio SA
SWB:F5D
|
FR |
|
W
|
Weichai Power Co Ltd
F:WI4
|
CN |
|
Symbotic Inc
NASDAQ:SYM
|
US |
|
W
|
Willis Towers Watson PLC
XMUN:WTY
|
UK |
|
Dingdong (Cayman) Ltd
F:945
|
CN |
|
C
|
CK Power PCL
SET:CKP
|
TH |
|
H
|
Hartford Financial Services Group Inc
F:HFF
|
US |
|
T
|
Tokyo Electron Ltd
DUS:TKY
|
JP |
Bankruptcy Probability
Capricor Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Capricor Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
1.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
444.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Capricor Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Capricor Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
